SCHEMBL21557588

SCHEMBL21557588

CCCCC(CCC)c1cn(C)nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25729184 0.90 HMGCR (0.31)
SCHEMBL24704471 0.86
SCHEMBL14023217 0.75 GPR84 (0.35)
SCHEMBL23265136 0.73 SMPD1 (0.48)
SCHEMBL24023303 0.71 CYP19A1 (0.36)
SCHEMBL24023271 0.71 SMPD1 (0.40)
SCHEMBL24775851 0.70 CYP19A1 (0.38)
SCHEMBL22541302 0.69 DDB1 (0.35)
SCHEMBL24849594 0.69 GABRA2 (0.33)
SCHEMBL16921661 0.69 SMPD1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3911645-B1 5-MEMBERED HETEROARYL COMPOUNDS CONTAINING A HYDROXAMATE MOIETY AND THEIR USE UNIV LILLE (FR) 2022-12-07 EP disclosed
EP-3566750-A2 CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS ImmunoGen, Inc. (US) 2019-11-13 EP disclosed